March 07, 2021 08:03 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Owner of abandoned SUV with explosives near Mukesh Ambani's house found dead | Russia welcomes agreements reached between India and China over border issues | 'Misleading': Centre on report that declined India's status to 'partly free' | Assam polls: BJP denies tickets to 11 sitting MLAs | Law of land supreme, stick to professional duties: Kiren Rijiju tells Taapsee Pannu's boyfriend Mathias over IT raids
Covid-19 vaccines approval spikes Sensex to new high Sensex-Nifty
Image Credit: UNI

Covid-19 vaccines approval spikes Sensex to new high

India Blooms News Service | @indiablooms | 04 Jan 2021, 05:08 pm

Mumbai/UNI: The benchmark Sensex rallied 307.82 points on Monday and closed at an all time high 48,176.80 as the investors' sentiments were lifted over emergency approval of two Covid-19 vaccines in India.

The Sensex registered 0.6 per cent increase, while Nifty jumped by 0.82 pc to close at record 14,132.90.

ONGC was the top gainer, rising around 4 per cent, followed by TCS, HCL Tech, Tech Mahindra, Infosys, M&M, HUL and L&T.

On the other hand, Kotak Bank, Bajaj Finance, Asian Paints, Titan and PowerGrid were among the laggards.

India, which has the second-highest Covid-19 infections in the world, on Sunday approved for emergency use two coronavirus vaccines – one developed by AstraZeneca and Oxford University and the other by local company Bharat Biotech.

The country is expected to start a massive immunisation program shortly. Serum Institute of India, the local maker of the AstraZeneca/Oxford vaccine.

In global markets, stock exchanges in Europe as well as in Shanghai, Seoul and Hong Kong ended on a positive note.